Thomas Ritter Selected Research

Thomas Ritter Research Topics

Disease

8	Inflammation (Inflammations) 10/2010 - 05/2002
5	Neoplasms (Cancer) 01/2021 - 01/2004
4	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 03/2010
4	Dacryocystitis (Dacryoadenitis) 06/2005 - 03/2002
3	Infections 01/2021 - 05/2002
2	Osteoarthritis 05/2016 - 03/2014
2	Reperfusion Injury 04/2007 - 10/2003
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2004 - 01/2004
1	Cognitive Dysfunction 04/2022
1	Dementia (Dementias) 04/2022
1	Glaucoma 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Ischemia 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2016
1	Colorectal Neoplasms (Colorectal Cancer) 09/2016
1	Wounds and Injuries (Trauma) 07/2016
1	Disease Progression 05/2016
1	Experimental Arthritis 12/2013
1	Retinal Diseases 01/2013
1	Atopic Dermatitis (Atopic Eczema) 08/2007
1	Contact Dermatitis (Eczema, Contact) 08/2007
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2007
1	Corneal Diseases (Corneal Disease) 05/2007
1	Cardiotoxicity 05/2007
1	Hypoxia (Hypoxemia) 05/2007
1	Corneal Neovascularization 01/2007
1	Pancreatitis 10/2006
1	Chronic Pancreatitis 09/2005
1	Fibrosis (Cirrhosis) 09/2005
1	Spontaneous Abortion (Miscarriage) 03/2005
1	Uremia 06/2004
1	Proteinuria 01/2003
1	Pneumonia (Pneumonitis) 11/2002
1	Respiratory Insufficiency (Respiratory Failure) 11/2002
1	Pneumocystis Infections 11/2002
1	Immune Reconstitution Inflammatory Syndrome 11/2002
1	Pulmonary Edema 11/2002

Drug/Important Bio-Agent (IBA)

5	Interleukin-10 (Interleukin 10)IBA 05/2016 - 03/2002
5	CytokinesIBA 08/2007 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 07/2016 - 01/2003
3	Heme Oxygenase-1IBA 08/2007 - 10/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2005 - 03/2002
3	Tumor Necrosis Factor InhibitorsIBA 06/2005 - 03/2002
2	Immunoglobulin G (IgG)IBA 01/2018 - 12/2013
2	AntigensIBA 03/2005 - 12/2004
1	Ginkgo ExtractIBA 04/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	daratumumabIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 11/2018
1	Granzymes (Granzyme)IBA 11/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	VaccinesIBA 01/2017
1	Collagenases (Collagenase)FDA Link 05/2016
1	Messenger RNA (mRNA)IBA 10/2010
1	OvalbuminIBA 08/2007
1	DinitrofluorobenzeneIBA 08/2007
1	protoporphyrin IXIBA 08/2007
1	Peptides (Polypeptides)IBA 07/2007
1	ChemokinesIBA 07/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2007
1	Cytochromes c (Cytochrome c)IBA 05/2007
1	Apoptosis Regulatory ProteinsIBA 05/2007
1	Caspase 9IBA 05/2007
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2007
1	Complementary DNA (cDNA)IBA 10/2006
1	InterleukinsIBA 10/2006
1	Interleukin-4 (Interleukin 4)IBA 09/2005
1	dibutyldichlorotinIBA 09/2005
1	AntibodiesIBA 12/2004
1	CreatinineIBA 06/2004
1	AutoantigensIBA 01/2004
1	Pharmaceutical PreparationsIBA 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2004
1	Biliverdine (Biliverdin)IBA 10/2003
1	IronIBA 10/2003
1	Carbon MonoxideIBA 10/2003
1	Heme (Haem)IBA 10/2003
1	EnzymesIBA 10/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2002
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2002
1	Hexadimethrine BromideIBA 05/2002

Therapy/Procedure

8	Therapeutics 01/2017 - 01/2004
3	Transplantation 01/2017 - 01/2013
2	Corneal Transplantation (Keratoplasty) 01/2021 - 05/2007
2	Immunotherapy 01/2017 - 09/2016
1	Immunomodulation 09/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2010
1	Liver Transplantation 04/2007
1	Drug Therapy (Chemotherapy) 01/2004
1	Highly Active Antiretroviral Therapy (HAART) 11/2002